Repligen (RGEN) Total Current Liabilities (2011 - 2026)
Repligen's (RGEN) quarterly Total Current Liabilities came in at $126.2 million in Q1 2026, down 16.97% year-on-year from $152.0 million in Q1 2025, and down 7.08% on a QoQ basis from $135.8 million in Q4 2025.
Repligen (RGEN) Total Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 16 years of Total Current Liabilities data on file, last reported at $126.2 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 16.97% year-over-year to $126.2 million in Q1 2026; TTM through Mar 2026 was $126.2 million, a 16.97% decrease from a year earlier, with the FY2025 full-year figure at $135.8 million, up 7.13% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $126.2 million, down from $135.8 million in the prior quarter.
- Over the last five years, Total Current Liabilities for RGEN reached as high as $424.3 million in Q1 2022 and fell as low as $108.4 million in Q3 2024.
- Historically, Total Current Liabilities has averaged $251.2 million across 5 years, with a median of $174.8 million in 2024.
- Across the five-year window, Total Current Liabilities jumped 35.43% in 2022 and tumbled 71.4% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $404.2 million in 2022, then plunged by 59.19% to $164.9 million in 2023, then fell by 23.13% to $126.8 million in 2024, then advanced by 7.13% to $135.8 million in 2025, then fell by 7.08% to $126.2 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $126.2 million in Q1 2026, $135.8 million in Q4 2025, and $131.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | 126.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.21 Mn |
| Dec 31, 2025 | 135.83 Mn |
| Sep 30, 2025 | 131.14 Mn |
| Jun 30, 2025 | 123.01 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Dec 31, 2024 | 126.79 Mn |
| Sep 30, 2024 | 108.37 Mn |
| Jun 30, 2024 | 174.81 Mn |
| Mar 31, 2024 | 181.55 Mn |
| Dec 31, 2023 | 164.94 Mn |
| Sep 30, 2023 | 378.94 Mn |
| Jun 30, 2023 | 388.35 Mn |
| Mar 31, 2023 | 416.56 Mn |
| Dec 31, 2022 | 404.20 Mn |
| Sep 30, 2022 | 410.70 Mn |
| Jun 30, 2022 | 423.52 Mn |
| Mar 31, 2022 | 424.33 Mn |
| Dec 31, 2021 | 375.26 Mn |
| Sep 30, 2021 | 349.44 Mn |
| Jun 30, 2021 | 332.34 Mn |